JP2015524432A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015524432A5 JP2015524432A5 JP2015524242A JP2015524242A JP2015524432A5 JP 2015524432 A5 JP2015524432 A5 JP 2015524432A5 JP 2015524242 A JP2015524242 A JP 2015524242A JP 2015524242 A JP2015524242 A JP 2015524242A JP 2015524432 A5 JP2015524432 A5 JP 2015524432A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- apolipoprotein
- protein
- biologically active
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261675549P | 2012-07-25 | 2012-07-25 | |
| US61/675,549 | 2012-07-25 | ||
| PCT/US2012/066334 WO2014018079A1 (en) | 2012-07-25 | 2012-11-21 | Method of treating hyperglycemic disorders using apoliprotein aiv |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015524432A JP2015524432A (ja) | 2015-08-24 |
| JP2015524432A5 true JP2015524432A5 (enExample) | 2016-01-21 |
| JP6033433B2 JP6033433B2 (ja) | 2016-11-30 |
Family
ID=47295208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015524242A Expired - Fee Related JP6033433B2 (ja) | 2012-07-25 | 2012-11-21 | アポリポタンパク質ａｉｖを用いて高血糖障害を治療する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10232019B2 (enExample) |
| JP (1) | JP6033433B2 (enExample) |
| AU (1) | AU2012385960B2 (enExample) |
| CA (1) | CA2878684A1 (enExample) |
| WO (1) | WO2014018079A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012100010A1 (en) | 2011-01-19 | 2012-07-26 | University Of Cincinnati | Apolipoprotein aiv as an antidiabetic peptide |
| MX357071B (es) * | 2012-01-19 | 2018-06-22 | Univ Cincinnati | Medicamentos que comprenden apolipoproteína a-iv no glicosilada para el tratamiento de diabetes. |
| JP2015524808A (ja) | 2012-07-25 | 2015-08-27 | ユニバーシティ・オブ・シンシナティ | アポリポタンパク質ａｉｖを用いたｉ型糖尿病の治療法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| FR2686605B1 (fr) | 1992-01-27 | 1994-03-11 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides, leur preparation et leur utilisation. |
| AU7242394A (en) | 1993-05-28 | 1994-12-20 | Merck & Co., Inc. | Method to control appetite and treat obesity |
| US7105489B2 (en) * | 2002-01-22 | 2006-09-12 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treating polycystic ovary syndrome |
| CN1668645A (zh) | 2002-05-17 | 2005-09-14 | 埃斯佩里安医疗公司 | 治疗缺血再灌注的方法和组合物 |
| US20100267052A1 (en) | 2006-09-01 | 2010-10-21 | American Type Culture Collection | Compositions and methods for diagnosis and treatment of type 2 diabetes |
| AU2009226246A1 (en) | 2008-03-21 | 2009-09-24 | Podiceps B.V. | Diagnostic of pre-symptomatic metabolic syndrome |
| CN103788043B (zh) | 2008-11-28 | 2016-02-03 | 中国医学科学院药物研究所 | 硝克柳胺化合物晶iv型、其制法和其药物组合物与用途 |
| WO2012100010A1 (en) * | 2011-01-19 | 2012-07-26 | University Of Cincinnati | Apolipoprotein aiv as an antidiabetic peptide |
| MX357071B (es) | 2012-01-19 | 2018-06-22 | Univ Cincinnati | Medicamentos que comprenden apolipoproteína a-iv no glicosilada para el tratamiento de diabetes. |
| WO2014011908A1 (en) * | 2012-07-11 | 2014-01-16 | Esperion Therapeutics, Inc. | Apolipoprotein mixtures |
| JP2015524808A (ja) | 2012-07-25 | 2015-08-27 | ユニバーシティ・オブ・シンシナティ | アポリポタンパク質ａｉｖを用いたｉ型糖尿病の治療法 |
-
2012
- 2012-11-21 US US14/416,541 patent/US10232019B2/en active Active
- 2012-11-21 WO PCT/US2012/066334 patent/WO2014018079A1/en not_active Ceased
- 2012-11-21 AU AU2012385960A patent/AU2012385960B2/en not_active Ceased
- 2012-11-21 JP JP2015524242A patent/JP6033433B2/ja not_active Expired - Fee Related
- 2012-11-21 CA CA2878684A patent/CA2878684A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cahn et al. | New forms of insulin and insulin therapies for the treatment of type 2 diabetes | |
| JP2014526441A5 (enExample) | ||
| JP6379300B2 (ja) | ＧＬＰ及び免疫グロブリンハイブリッドＦｃ融合ポリペプチド及びその用途 | |
| JP2010031018A5 (enExample) | ||
| JP2020062028A5 (enExample) | ||
| EP2611458B1 (en) | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 | |
| US7485620B2 (en) | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | |
| JP2014501762A5 (enExample) | ||
| RU2013133803A (ru) | Способы лечения метаболических нарушений и ожирения при помощи пептидов на основе глюкагона, активных по отношению к рецепторам гип и гпп | |
| US20130338071A1 (en) | GLP-1 Agonist and Cardiovascular Complications | |
| JP2010530368A (ja) | インスリン誘導体を含有する薬学的製剤 | |
| JP2017501381A5 (enExample) | ||
| US20140220029A1 (en) | Combined use of a modulator of cd3 and a glp-1 compound | |
| JP2010514694A5 (enExample) | ||
| JP2015504073A5 (enExample) | ||
| JP2016514132A (ja) | ヒト成長ホルモン類似体を用いた小児成長ホルモン分泌不全症の治療 | |
| JP2012509283A5 (enExample) | ||
| TW200824706A (en) | Methods for administering long-lasting hypoglycemic agents | |
| Garg | New insulin analogues | |
| EP1515749A1 (en) | Combined use of a modulator of cd3 and a glp-1 compound | |
| JP2020502150A5 (enExample) | ||
| JP2020502056A5 (enExample) | ||
| JP2020502151A5 (enExample) | ||
| CN1993137A (zh) | 用于治疗心血管疾病的组合物和方法 | |
| JP2014504601A5 (enExample) |